cyqualon has been researched along with dibenzylidene acetone in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arbiser, JL; Bai, X; Bowen, JP; Ehlers, T; Goldsmith, DJ; Hubbard IV, RB; Robinson, TP | 1 |
| Bahety, P; Boon, CP; Ee, PL; Lee, CY; Leow, PC; Tan, KL; Yang, T | 1 |
| Deck, LM; Hunsaker, LA; Royer, RE; Vander Jagt, DL; Vander Jagt, TA; Whalen, LJ | 1 |
3 other study(ies) available for cyqualon and dibenzylidene acetone
| Article | Year |
|---|---|
Design, synthesis, and biological evaluation of angiogenesis inhibitors: aromatic enone and dienone analogues of curcumin.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Cell Division; Cell Line, Transformed; Curcumin; Drug Design; Endothelium, Vascular; Ketones; Mice; Polyenes; Structure-Activity Relationship | 2003 |
Functionalized curcumin analogs as potent modulators of the Wnt/β-catenin signaling pathway.
Topics: Antineoplastic Agents; beta Catenin; Bone Neoplasms; Cell Line, Tumor; Curcumin; HEK293 Cells; Humans; Neoplasm Invasiveness; Osteosarcoma; Wnt Signaling Pathway | 2014 |
Activation of anti-oxidant Nrf2 signaling by enone analogues of curcumin.
Topics: Curcumin; Dose-Response Relationship, Drug; Hep G2 Cells; Humans; Ketones; Molecular Structure; NF-E2-Related Factor 2; Oxidants; Signal Transduction; Structure-Activity Relationship | 2018 |